Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04688450 · ClinicalTrials.gov registry record · NA
BP Management System User Acceptance Testing
A NA study of Hypotension and Shock, sponsored by Andrew Tomas Reisner.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04688450: Completed NA study of Hypotension and Shock, sponsored by Andrew Tomas Reisner.
NCT04688450 is a NA study of Hypotension and Shock that has completed, run by Andrew Tomas Reisner. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04688450, a NA study of Hypotension and Shock, has completed, sponsored by Andrew Tomas Reisner.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a feasibility study for an investigational clinical decision support system ("the System") intended to optimize the management of blood pressure (BP) for patients during vasopressor infusion. The investigational outcomes are the perceptions of the nurse-subjects who are managing the BP of the patient-subjects; the operational performance of the System; and any technical failures of the software during real-time operation.
Primary Outcome
Nurse-subject quantitative survey response (yes/no) about any confusion or perceived inaccuracies of the system; perceived risk of patient management error; or perceived distraction that impacted care delivery
Conditions Studied
Interventions
- DEVICE VIGORIS Blood Pressure Management Clinical Decision Support System
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-01-21 |
| Est. Completion | 2023-05-31 |
| Phase | NA |
What the finished NCT04688450 record still lists
NCT04688450 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Hypotension and Shock appearing as the primary indexed condition, and to 1 intervention - of which VIGORIS Blood Pressure Management Clinical Decision Support System is the first listed.
NCT04688450 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04688450 about?
NCT04688450 is a clinical study titled "BP Management System User Acceptance Testing". This is a feasibility study for an investigational clinical decision support system ("the System") intended to optimize the management of blood pressure (BP) for patients during vasopressor infusion. The investigational outcomes are the perceptions of the nurse-subjects who are managing the BP of th...
What is the current status of trial NCT04688450?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-01-21. Estimated completion is 2023-05-31.
What conditions does trial NCT04688450 study?
This clinical trial studies the following conditions: Hypotension and Shock.
What interventions are being tested in trial NCT04688450?
The interventions under investigation include: VIGORIS Blood Pressure Management Clinical Decision Support System (DEVICE).
Who is sponsoring clinical trial NCT04688450?
This trial is sponsored by Andrew Tomas Reisner, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04688450 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypotension and Shock
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04688450's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI